Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion type Assertion NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_head.
- NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion description "[This case fits with and extends a recently proposed multistage AML model in which constitutive activation of tyrosine kinases by mutations (BCR-ABL1) are associated with deregulation of transcription factors central to myeloid differentiation (HOXA9 secondary to PICALM-MLLT10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_provenance.
- NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion evidence source_evidence_literature NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_provenance.
- NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion SIO_000772 16518848 NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_provenance.
- NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion wasDerivedFrom befree-2016 NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_provenance.
- NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_assertion wasGeneratedBy ECO_0000203 NP538875.RAVZldd1CXf6Spgvv7so7AKBdBF9WSkGzUoEV9PHY_RsE130_provenance.